PDB Short entry for 1Q7D HEADER CONTRACTILE PROTEIN 18-AUG-03 1Q7D TITLE STRUCTURE OF THE INTEGRIN ALPHA2BETA1 BINDING COLLAGEN TITLE 2 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: COLLAGEN ALFA 1(I) CHAIN PEPTIDE COMPND 3 GPOGPOGFOGERGPOGPOGPO; COMPND 4 CHAIN: A, B, C; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SOURCE 4 SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS SOURCE 5 (HUMAN). PEPTIDE SYNTHESISED USING STANDARD FMOC SYNTHESIS KEYWDS COLLAGEN, INTEGRIN, TRIPLEHELIX, CONTRACTILE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.EMSLEY,C.G.KNIGHT,R.W.FARNDALE,M.J.BARNES REVDAT 2 24-FEB-09 1Q7D 1 VERSN REVDAT 1 13-JAN-04 1Q7D 0 JRNL AUTH J.EMSLEY,C.G.KNIGHT,R.W.FARNDALE,M.J.BARNES JRNL TITL STRUCTURE OF THE INTEGRIN ALPHA2BETA1-BINDING JRNL TITL 2 COLLAGEN PEPTIDE. JRNL REF J.MOL.BIOL. V. 335 1019 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 14698296 JRNL DOI 10.1016/J.JMB.2003.11.030 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 5.4 REMARK 3 NUMBER OF REFLECTIONS : 4865 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : RFREE REMARK 3 FREE R VALUE TEST SET SELECTION : 5% REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 265 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.88 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3580 REMARK 3 BIN FREE R VALUE : 0.4850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 22 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 429 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 0.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : -0.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.43400 REMARK 3 B22 (A**2) : 1.37500 REMARK 3 B33 (A**2) : 1.05900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.10 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.60 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 9.50 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q7D COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-03. REMARK 100 THE RCSB ID CODE IS RCSB020008. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JAN-01 REMARK 200 TEMPERATURE (KELVIN) : 85 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5060 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.10500 REMARK 200 R SYM (I) : 0.10500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.35500 REMARK 200 R SYM FOR SHELL (I) : 0.35500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8K, PH 8.0, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 12.70000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 12.70000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 14.80000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 67.90000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 14.80000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 67.90000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 12.70000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 14.80000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 67.90000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 12.70000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 14.80000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 67.90000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 3820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 24 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 113 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 107 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 116 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HYP C 22 REMARK 465 NH2 C 23 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 115 O HOH B 115 3554 1.71 REMARK 500 O HOH B 90 O HOH B 90 3555 1.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 24 DISTANCE = 8.57 ANGSTROMS REMARK 525 HOH A 58 DISTANCE = 8.15 ANGSTROMS REMARK 525 HOH A 75 DISTANCE = 7.21 ANGSTROMS REMARK 525 HOH A 76 DISTANCE = 9.53 ANGSTROMS REMARK 525 HOH A 94 DISTANCE = 9.14 ANGSTROMS REMARK 525 HOH C 125 DISTANCE = 5.95 ANGSTROMS REMARK 525 HOH A 113 DISTANCE = 7.35 ANGSTROMS REMARK 525 HOH B 122 DISTANCE = 5.60 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE B 1 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE C 1 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 23 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 B 23 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DZI RELATED DB: PDB REMARK 900 THE SAME COLLAGEN PEPTIDE IN COMPLEX WITH INTEGRIN A2 I REMARK 900 DOMAIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PEPTIDE IS ACETYLATED AT THE N-TERMINUS REMARK 999 AND AMIDATED AT THE C-TERMINUS. REMARK 999 GLY-PRO-HYP GROUPS WERE ADDED FOR STABILIZATION. DBREF 1Q7D A 8 13 UNP P02452 CO1A1_HUMAN 680 685 DBREF 1Q7D B 8 13 UNP P02452 CO1A1_HUMAN 680 685 DBREF 1Q7D C 8 13 UNP P02452 CO1A1_HUMAN 680 685 SEQADV 1Q7D GLY A 2 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO A 3 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP A 4 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY A 5 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO A 6 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP A 7 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP A 10 UNP P02452 PRO 682 MODIFIED RESIDUE SEQADV 1Q7D GLY A 14 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO A 15 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP A 16 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY A 17 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO A 18 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP A 19 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY A 20 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO A 21 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP A 22 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY B 2 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO B 3 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP B 4 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY B 5 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO B 6 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP B 7 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP B 10 UNP P02452 PRO 682 MODIFIED RESIDUE SEQADV 1Q7D GLY B 14 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO B 15 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP B 16 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY B 17 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO B 18 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP B 19 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY B 20 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO B 21 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP B 22 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY C 2 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO C 3 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP C 4 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY C 5 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO C 6 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP C 7 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP C 10 UNP P02452 PRO 682 MODIFIED RESIDUE SEQADV 1Q7D GLY C 14 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO C 15 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP C 16 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY C 17 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO C 18 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP C 19 UNP P02452 SEE REMARK 999 SEQADV 1Q7D GLY C 20 UNP P02452 SEE REMARK 999 SEQADV 1Q7D PRO C 21 UNP P02452 SEE REMARK 999 SEQADV 1Q7D HYP C 22 UNP P02452 SEE REMARK 999 SEQRES 1 A 23 ACE GLY PRO HYP GLY PRO HYP GLY PHE HYP GLY GLU ARG SEQRES 2 A 23 GLY PRO HYP GLY PRO HYP GLY PRO HYP NH2 SEQRES 1 B 23 ACE GLY PRO HYP GLY PRO HYP GLY PHE HYP GLY GLU ARG SEQRES 2 B 23 GLY PRO HYP GLY PRO HYP GLY PRO HYP NH2 SEQRES 1 C 23 ACE GLY PRO HYP GLY PRO HYP GLY PHE HYP GLY GLU ARG SEQRES 2 C 23 GLY PRO HYP GLY PRO HYP GLY PRO HYP NH2 MODRES 1Q7D HYP A 4 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP A 7 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP A 10 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP A 16 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP A 19 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP A 22 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP B 4 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP B 7 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP B 10 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP B 16 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP B 19 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP B 22 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP C 4 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP C 7 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP C 10 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP C 16 PRO 4-HYDROXYPROLINE MODRES 1Q7D HYP C 19 PRO 4-HYDROXYPROLINE HET ACE A 1 3 HET HYP A 4 8 HET HYP A 7 8 HET HYP A 10 8 HET HYP A 16 8 HET HYP A 19 8 HET HYP A 22 8 HET NH2 A 23 1 HET ACE B 1 3 HET HYP B 4 8 HET HYP B 7 8 HET HYP B 10 8 HET HYP B 16 8 HET HYP B 19 8 HET HYP B 22 8 HET NH2 B 23 1 HET ACE C 1 3 HET HYP C 4 8 HET HYP C 7 8 HET HYP C 10 8 HET HYP C 16 8 HET HYP C 19 8 HETNAM ACE ACETYL GROUP HETNAM HYP 4-HYDROXYPROLINE HETNAM NH2 AMINO GROUP HETSYN HYP HYDROXYPROLINE FORMUL 1 ACE 3(C2 H4 O) FORMUL 1 HYP 17(C5 H9 N O3) FORMUL 1 NH2 2(H2 N) FORMUL 4 HOH *94(H2 O) LINK C ACE A 1 N GLY A 2 1555 1555 1.33 LINK C HYP A 22 N NH2 A 23 1555 1555 1.33 LINK C ACE B 1 N GLY B 2 1555 1555 1.33 LINK C HYP B 22 N NH2 B 23 1555 1555 1.33 LINK C ACE C 1 N GLY C 2 1555 1555 1.33 LINK C PRO A 3 N HYP A 4 1555 1555 1.35 LINK C HYP A 4 N GLY A 5 1555 1555 1.33 LINK C PRO A 6 N HYP A 7 1555 1555 1.34 LINK C HYP A 7 N GLY A 8 1555 1555 1.33 LINK C PHE A 9 N HYP A 10 1555 1555 1.35 LINK C HYP A 10 N GLY A 11 1555 1555 1.33 LINK C PRO A 15 N HYP A 16 1555 1555 1.35 LINK C HYP A 16 N GLY A 17 1555 1555 1.33 LINK C PRO A 18 N HYP A 19 1555 1555 1.34 LINK C HYP A 19 N GLY A 20 1555 1555 1.33 LINK C PRO A 21 N HYP A 22 1555 1555 1.34 LINK C PRO B 3 N HYP B 4 1555 1555 1.34 LINK C HYP B 4 N GLY B 5 1555 1555 1.33 LINK C PRO B 6 N HYP B 7 1555 1555 1.34 LINK C HYP B 7 N GLY B 8 1555 1555 1.33 LINK C PHE B 9 N HYP B 10 1555 1555 1.34 LINK C HYP B 10 N GLY B 11 1555 1555 1.33 LINK C PRO B 15 N HYP B 16 1555 1555 1.35 LINK C HYP B 16 N GLY B 17 1555 1555 1.33 LINK C PRO B 18 N HYP B 19 1555 1555 1.34 LINK C HYP B 19 N GLY B 20 1555 1555 1.33 LINK C PRO B 21 N HYP B 22 1555 1555 1.34 LINK C PRO C 3 N HYP C 4 1555 1555 1.34 LINK C HYP C 4 N GLY C 5 1555 1555 1.33 LINK C PRO C 6 N HYP C 7 1555 1555 1.34 LINK C HYP C 7 N GLY C 8 1555 1555 1.33 LINK C PHE C 9 N HYP C 10 1555 1555 1.35 LINK C HYP C 10 N GLY C 11 1555 1555 1.33 LINK C PRO C 15 N HYP C 16 1555 1555 1.34 LINK C HYP C 16 N GLY C 17 1555 1555 1.33 LINK C PRO C 18 N HYP C 19 1555 1555 1.34 LINK C HYP C 19 N GLY C 20 1555 1555 1.33 SITE 1 AC2 2 GLY A 2 HOH B 61 SITE 1 AC3 3 PRO A 3 HOH C 62 HOH C 128 SITE 1 AC4 3 HYP A 22 PRO B 21 GLY C 20 SITE 1 AC5 1 HYP B 22 CRYST1 29.600 135.800 25.400 90.00 90.00 90.00 C 2 2 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.033784 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007364 0.000000 0.00000 SCALE3 0.000000 0.000000 0.039370 0.00000 HETATM 1 C ACE A 1 1.068 -0.047 2.588 1.00 36.09 C HETATM 2 O ACE A 1 1.828 -0.254 3.534 1.00 37.28 O HETATM 3 CH3 ACE A 1 -0.318 -0.640 2.568 1.00 36.87 C